ABCL vs CMS · rev $28.8M vs P/E 20, $22.42B cap
Abcellera Biologics Inc (ABCL) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
CMS does not have a complete income-statement cache yet.
ABCL currently screens at market cap $1.12B. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the ABCL and CMS stock pages for the full models.
Not investment advice.